Literature DB >> 18628248

Quercetin inhibition of tumor invasion via suppressing PKC delta/ERK/AP-1-dependent matrix metalloproteinase-9 activation in breast carcinoma cells.

Cheng-Wei Lin1, Wen-Chi Hou, Shing-Chuan Shen, Shu-Hui Juan, Ching-Huai Ko, Ling-Mei Wang, Yen-Chou Chen.   

Abstract

Quercetin (QUE; 3,5,7,3',4'-tetrahydroxyflavone) has been shown to possess several beneficial biological activities including antitumor, anti-inflammation and antioxidant properties; however, the effects of QUE in preventing invasion by breast carcinoma cells are still undefined. Increases in the protein, messenger RNA and enzyme activity levels of matrix metalloproteinase (MMP)-9 were observed in 12-O-tetradecanoylphorbol-13-acetate (TPA)-treated MCF-7 cells, and these were blocked by QUE, but not by quercitrin or rutin. A translocation of protein kinase C (PKC)delta from the cytosol to the membrane followed by activation of extracellular signal-regulated kinase (ERK) and c-Jun/activator protein-1 (AP-1) by TPA was demonstrated, and TPA-induced MMP-9 activation and migration were inhibited by the pan PKC inhibitor, GF109203X, the specific PKCdelta inhibitor, rottlerin, an ERK inhibitor (PD98059) and an AP-1 inhibitor (curcumin). Application of QUE significantly suppressed TPA-induced activation of the PKCdelta/ERK/AP-1-signaling cascade. To elucidate the importance of hydroxyl (OH) substitutions to QUE's inhibition of tumor migration, several structurally related flavones of QUE including 3',4'-diOH, 3',4'-diOCH(3), 3,5,7-triOH, 3,4',4'-triOH, 3,3',4'-triOCH(3), luteolin and fisetin were used. Results suggested that OH groups at both C3' and C4' play central roles in QUE's inhibition of TPA-induced MMP-9 activation and migration, and an additional OH at C3, C5 or C7 may increase the inhibitory potency of the 3',4'-diOH flavone against TPA-induced MMP-9 activity and migration. The antitumor invasion and migration effects of breast carcinoma cells induced by QUE with the structure-activity relationship analysis were identified.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18628248     DOI: 10.1093/carcin/bgn162

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  57 in total

1.  Hispolon inhibits TPA-induced invasion by reducing MMP-9 expression through the NF-κB signaling pathway in MDA-MB-231 human breast cancer cells.

Authors:  Yi-Sheng Sun; Zhao Zhao; Han-Ping Zhu
Journal:  Oncol Lett       Date:  2015-05-18       Impact factor: 2.967

2.  Quercitrin protects skin from UVB-induced oxidative damage.

Authors:  Yuanqin Yin; Wenqi Li; Young-Ok Son; Lijuan Sun; Jian Lu; Donghern Kim; Xin Wang; Hua Yao; Lei Wang; Poyil Pratheeshkumar; Andrew J Hitron; Jia Luo; Ning Gao; Xianglin Shi; Zhuo Zhang
Journal:  Toxicol Appl Pharmacol       Date:  2013-03-29       Impact factor: 4.219

3.  Quercetin and sulforaphane in combination suppress the progression of melanoma through the down-regulation of matrix metalloproteinase-9.

Authors:  Saurabh J Pradhan; Rosalin Mishra; Priyanka Sharma; Gopal C Kundu
Journal:  Exp Ther Med       Date:  2010-08-26       Impact factor: 2.447

4.  Inhibitory effect of phytoglycoprotein (38 kDa) on expression of matrix metalloproteinase-9 in 12-O-tetradecanoylphorbol-13-acetate-treated HepG2cells.

Authors:  Jin Lee; Kye-Taek Lim
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-06-29       Impact factor: 3.000

5.  TF/FVIIa/PAR2 promotes cell proliferation and migration via PKCα and ERK-dependent c-Jun/AP-1 pathway in colon cancer cell line SW620.

Authors:  Lichao Hu; Longfei Xia; Hong Zhou; Biao Wu; Yuan Mu; Ying Wu; Jinchuan Yan
Journal:  Tumour Biol       Date:  2013-04-25

6.  Serum cytokine concentrations, flavonol intake and colorectal adenoma recurrence in the Polyp Prevention Trial.

Authors:  G Bobe; G Murphy; P S Albert; L B Sansbury; E Lanza; A Schatzkin; N H Colburn; A J Cross
Journal:  Br J Cancer       Date:  2010-10-05       Impact factor: 7.640

Review 7.  Molecular mechanisms of action of quercetin in cancer: recent advances.

Authors:  Dharambir Kashyap; Sonam Mittal; Katrin Sak; Paavan Singhal; Hardeep Singh Tuli
Journal:  Tumour Biol       Date:  2016-07-22

8.  Inhibition of MMP-3 activity and invasion of the MDA-MB-231 human invasive breast carcinoma cell line by bioflavonoids.

Authors:  Kanokkarn Phromnoi; Supachai Yodkeeree; Songyot Anuchapreeda; Pornngarm Limtrakul
Journal:  Acta Pharmacol Sin       Date:  2009-07-20       Impact factor: 6.150

Review 9.  Polyphenol compounds and PKC signaling.

Authors:  Joydip Das; Rashmi Ramani; M Olufemi Suraju
Journal:  Biochim Biophys Acta       Date:  2016-06-29

Review 10.  Role of ER-α36 in breast cancer by typical xenoestrogens.

Authors:  Jun Liu; Zhixiang Xu; Xiaodong Ma; Bin Huang; Xuejun Pan
Journal:  Tumour Biol       Date:  2015-09-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.